"Immune Tregs Enhance Stem Cell Therapy for Parkinson's: Study"
Co-transplanting stem cells with regulatory T-cells (Tregs) has been shown to enhance cell survival and alleviate motor symptoms in rodent models of Parkinson's disease. This breakthrough suggests a new strategy to improve clinical outcomes for stem cell-based therapies in humans. The study found that the presence of Tregs increased the survival of transplanted dopamine-producing nerve cells and suppressed the outgrowth of non-dopaminergic cells. These findings have implications for other neurodegenerative disorders and highlight the importance of safety in cell therapy. Future studies are needed to assess the safety and mechanisms of this co-transplantation approach.
